RF shield for an implantable lead

US9402996B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9402996-B2
Application numberUS-201514619460-A
CountryUS
Kind codeB2
Filing dateFeb 11, 2015
Priority dateFeb 11, 2014
Publication dateAug 2, 2016
Grant dateAug 2, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Various embodiments concern shielding an implantable lead from RF energy associated with MRI scans. The lead can include a distal region, a proximal region, an intermediate region between the distal region and the proximal region, at least one electrode disposed on the distal region, and at least one conductor extending from the proximal region to the at least one electrode. Implanting of the lead can include coiling a portion of the intermediate region to define one or more loops and selectively shielding the one or more loops of the lead with a RF shield. The RF shield can comprise metallic material and can be configured to reduce RF signal coupling to the at least one conductor along the one or more loops.

First claim

Opening claim text (preview).

We claim: 1. A method of shielding an implantable lead, the method comprising: implanting a lead in a patient, the lead having a distal region, a proximal region, an intermediate region between the distal region and the proximal region, at least one electrode disposed on the distal region, and at least one conductor extending from the proximal region to the at least one electrode; coiling a portion of the intermediate region to define one or more loops; and selectively shielding the one or more loops of the lead with an RF shield, the RF shield comprising metallic material and configured to reduce RF signal coupling to the at least one conductor along the one or more loops. 2. The method of claim 1 , wherein the RF shield comprises a metallic bag, and selectively shielding the portion of the intermediate region comprises placing the metallic bag over the one or more loops. 3. The method of claim 1 , wherein the RF shield comprises a flexible metallic sleeve, and selectively shielding the one or more loops comprises sliding the flexible metallic sleeve over the portion of the intermediate region. 4. The method of claim 1 , wherein the lead comprises a polymeric body defining an exterior surface of the lead, the RF shield is a layer of metallic material deposited on the exterior surface only along the portion of the lead, and selectively shielding the one or more loops of the lead comprises coiling the portion of the lead on which the layer of metallic material is deposited into the one or more loops. 5. The method of claim 1 , wherein selectively shielding the one or more loops of the lead comprises placing the RF shield over the intermediate region, and wherein the method further comprises removing the RF shield from over the intermediate region while leaving the lead implanted within the patient. 6. The method of claim 1 , wherein the RF shield includes an identification tag indicating MRI conditional compatibility, and the method further comprises transcutaneously reading the indication of MRI conditional compatibility from the identification tag while the lead is implanted in the patient. 7. The method of claim 1 , wherein the RF shield is placed along the lead in the selectively shielding step such that no portion of the RF shield extends into the vasculature of the patient. 8. The method of claim 1 , wherein the lead is shielded in the selectively shielding step such that only the one or more loops are shielded by the RF shield. 9. The method of claim 1 , further comprising suturing the RF shield to one or both of fix the RF shield in position over the lead and anchor the RF shield at an implant location. 10. An implantable lead having a distal region, a proximal region, and an intermediate region therebetween, the lead comprising: at least one electrode disposed on the distal region of the lead; at least one conductor extending from the proximal region to the distal region, the at least one conductor electrically coupled to the at least one electrode, respectively; a polymeric body radially surrounding the at least one conductor, the polymeric body extending from the proximal region to the distal region, the polymeric body configured to electrically insulate the at least one conductor; and an RF shield surrounding an outer surface of the polymeric body and only along the intermediate region of the elongated member, the lead configured to be coiled into one or more loops along the intermediate region, the RF shield configured to reduce RF signal coupling to the at least one conductor along the one or more loops. 11. The lead of claim 10 , wherein the RF shield is selectively moveable over the intermediate region. 12. The lead of claim 10 , wherein the RF shield includes at least one of a metallic film and a metallic mesh. 13. The lead of claim 10 , wherein the RF shield comprises a metallic bag configured to envelope the one or more loops. 14. The lead of claim 10 , wherein the RF shield comprises a sleeve configured to slide over the lead. 15. The lead of claim 10 , wherein the RF shield comprises a metallic layer deposited on an exterior surface of the polymeric body. 16. The lead of claim 10 , wherein the RF shield only shields the one or more loops of the lead. 17. The lead of claim 10 , wherein the RF shield is configured to be removed from the lead after implantation while allowing the lead to remain implanted. 18. The lead of claim 10 , wherein the RF shield includes a remotely readable identification tag indicating magnetic resonance conditional usage. 19. An implantable lead, the lead comprising: a lead body, the lead body configured to be coiled into one or more loops; at least one electrode; at least one conductor extending within the lead body, the at least one conductor electrically coupled to the at least one electrode, respectively; and an RF shield, the RF shield moveable over the lead body and removable from the lead body, the RF shield configured to surround the one or more loops and reduce RF signal coupling to the at least one conductor along the one or more loops. 20. The lead of claim 19 , wherein the RF shield only shields the one or more loops of the lead.

Assignees

Inventors

Classifications

  • A61N1/056Primary

    Transvascular endocardial electrode systems · CPC title

  • Human Necessities · mapped topic

  • A61N1/3718Primary

    Monitoring of or protection against external electromagnetic fields or currents · CPC title

  • A61N1/08Primary

    Arrangements or circuits for monitoring, protecting, controlling or indicating {(for external stimulators A61N1/3603; for implantable neurostimulators A61N1/36128; for heart stimulators A61N1/37; for defibrillators A61N1/3925)} · CPC title

  • having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9402996B2 cover?
Various embodiments concern shielding an implantable lead from RF energy associated with MRI scans. The lead can include a distal region, a proximal region, an intermediate region between the distal region and the proximal region, at least one electrode disposed on the distal region, and at least one conductor extending from the proximal region to the at least one electrode. Implanting of the l…
Who is the assignee on this patent?
Cardiac Pacemakers Inc
What technology area does this patent fall under?
Primary CPC classification A61N1/056. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).